StonvexLoading…
StonvexStonvexStonvexCore line items from GTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $305.30M | $310.20M | $1.25B | $930.40M | $612.40M |
Operating Income | Not available | $57.90M | $225.70M | $171.50M | $104.00M |
Net Income | Not available | $29.30M | $124.20M | $89.50M | $24.00M |
EPS (Diluted) | $0.27 | $0.10 | $0.38 | $0.27 | $0.15 |
Total Assets | Not available | $6.37B | $6.44B | $6.37B | $6.45B |
Total Liabilities | Not available | $4.90B | $4.93B | $4.84B | $4.90B |
Cash & Equivalents | Not available | $171.20M | $175.90M | $124.80M | $171.00M |
Free Cash Flow OCF − CapEx | Not available | $90.60M | $389.30M | $262.20M | $191.30M |
Shares Outstanding | Not available | 296.08M | 307.29M | 313.77M | 320.56M |